EUVIMEDEUVIMED entdecken
Open Access

Tecovirimat Use under Expanded Access to Treat Mpox in the United States, 2022–2023

Patricia A Yu, Riad Elmor, Kalimah Muhammad, Yon C Yu, Agam K Rao

NEJM Evidence · 2024

DOI: 10.1056/evidoa2400189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NEJM Evidence, 2024. Verfasst von Patricia A Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Office of Readiness and Response, Centers for Disease Control and Prevention, Atlanta. Hauptthemen laut MEDLINE: Antiviral Agents, Mpox, Monkeypox. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsMpox, MonkeypoxHumansUnited StatesMaleFemaleAdultMiddle AgedAdolescentYoung AdultAgedIsoindolesChildBenzamidesChild, PreschoolPhthalimides

Substanzen

Antiviral AgentstecovirimatIsoindolesBenzamidesPhthalimides

Autor:innen und Institutionen

  • Office of Readiness and Response, Centers for Disease Control and Prevention, Atlanta.
  • Booz Allen Hamilton, McLean, VA.
  • Cherokee Nation Integrated Health, Tulsa, OK.
  • Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta.

Förderung

  • Intramural CDC HHS

Zitieren

APA

Yu, P. A., Elmor, R., Muhammad, K., Yu, Y. C., & Rao, A. K. (2024). Tecovirimat Use under Expanded Access to Treat Mpox in the United States, 2022–2023. NEJM Evidence. https://doi.org/10.1056/evidoa2400189

Vancouver

Yu PA, Elmor R, Muhammad K, Yu YC, Rao AK. Tecovirimat Use under Expanded Access to Treat Mpox in the United States, 2022–2023. NEJM Evidence. 2024. doi:10.1056/evidoa2400189

BibTeX
@article{Yu2024,
  author = {Yu, Patricia A and Elmor, Riad and Muhammad, Kalimah and Yu, Yon C and Rao, Agam K},
  title = {Tecovirimat Use under Expanded Access to Treat Mpox in the United States, 2022–2023},
  journal = {NEJM Evidence},
  year = {2024},
  doi = {10.1056/evidoa2400189}
}
Kostenlos starten →